カテゴリー： 世界, 医療/バイオ, LP Information

世界の結合型ワクチン市場予測 2023年-2029年

【英語タイトル】Global Conjugate Vaccines Market Growth 2023-2029

LP Informationが出版した調査資料（LP23MY4386）・商品コード：LP23MY4386
・発行会社（調査会社）：LP Information
・発行日：2023年5月
・ページ数：105
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医療機器＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥549,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥823,500見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,098,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の結合型ワクチン市場」は、過去の販売実績から2022年の世界の結合型ワクチンの総販売量を検討し、2023年から2029年の予測される結合型ワクチンの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の結合型ワクチンの市場規模を掲載し、XXX百万米ドル規模の世界の結合型ワクチン市場の詳細な分析を提供します。本インサイトレポートは、世界の結合型ワクチン業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の結合型ワクチン市場における各社の独自のポジションをより深く理解するために、結合型ワクチン製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の結合型ワクチン市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。結合型ワクチンの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。結合型ワクチンの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。結合型ワクチンのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

結合型ワクチンの世界主要メーカーとしては、Novartis、 Neuron Biotech、 Serum Institute of India、 Pfizer、 Sanofi Pasteur、 Bharat Biotech、 Biological、 GlaxoSmithKline、 Merck、 CSLなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の結合型ワクチン市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では結合型ワクチン市場をセグメンテーションし、種類別 (一価結合型ワクチン、多価結合型ワクチン)、用途別 (子供、大人)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：一価結合型ワクチン、多価結合型ワクチン

・用途別区分：子供、大人

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の結合型ワクチン市場の10年間の市場状況・展望は？
・世界および地域別に見た結合型ワクチン市場成長の要因は何か？
・結合型ワクチンの市場機会はエンドマーケットの規模によってどのように変化するのか？
・結合型ワクチンのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：結合型ワクチンの年間販売量2018-2029、地域別現状・将来分析
・結合型ワクチンの種類別セグメント：一価結合型ワクチン、多価結合型ワクチン
・結合型ワクチンの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・結合型ワクチンの用途別セグメント：子供、大人
・結合型ワクチンの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の結合型ワクチン市場
・企業別のグローバル結合型ワクチン市場データ：2018-2023年の年間販売量、市場シェア
・企業別の結合型ワクチンの年間売上：2018-2023年の売上、市場シェア
・企業別の結合型ワクチン販売価格
・主要企業の結合型ワクチン生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

結合型ワクチンの地域別レビュー
・地域別の結合型ワクチン市場規模2018-2023：年間販売量、売上
・主要国別の結合型ワクチン市場規模2018-2023：年間販売量、売上
・南北アメリカの結合型ワクチン販売の成長
・アジア太平洋の結合型ワクチン販売の成長
・ヨーロッパの結合型ワクチン販売の成長
・中東・アフリカの結合型ワクチン販売の成長

南北アメリカ市場
・南北アメリカの国別の結合型ワクチン販売量、売上（2018-2023）
・南北アメリカの結合型ワクチンの種類別販売量
・南北アメリカの結合型ワクチンの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の結合型ワクチン販売量、売上（2018-2023）
・アジア太平洋の結合型ワクチンの種類別販売量
・アジア太平洋の結合型ワクチンの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の結合型ワクチン販売量、売上（2018-2023）
・ヨーロッパの結合型ワクチンの種類別販売量
・ヨーロッパの結合型ワクチンの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の結合型ワクチン販売量、売上（2018-2023）
・中東・アフリカの結合型ワクチンの種類別販売量
・中東・アフリカの結合型ワクチンの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・結合型ワクチンの製造コスト構造分析
・結合型ワクチンの製造プロセス分析
・結合型ワクチンの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・結合型ワクチンの主要なグローバル販売業者
・結合型ワクチンの主要なグローバル顧客

地域別の結合型ワクチン市場予測レビュー
・地域別の結合型ワクチン市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・結合型ワクチンの種類別市場規模予測
・結合型ワクチンの用途別市場規模予測

主要企業分析
Novartis、 Neuron Biotech、 Serum Institute of India、 Pfizer、 Sanofi Pasteur、 Bharat Biotech、 Biological、 GlaxoSmithKline、 Merck、 CSL
・企業情報
・結合型ワクチン製品
・結合型ワクチン販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

Vaccines are used to prevent diseases by invoking an immune response to an antigen, the foreign part of a bacteria or virus that the immune system recognizes. Conjugate vaccines combine a weak antigen with a strong antigen as a carrier so that the immune system has a stronger response to the weak antigen.
LPI (LP Information)’ newest research report, the “Conjugate Vaccines Industry Forecast” looks at past sales and reviews total world Conjugate Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Conjugate Vaccines sales for 2023 through 2029. With Conjugate Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Conjugate Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Conjugate Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Conjugate Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Conjugate Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Conjugate Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Conjugate Vaccines.
The global Conjugate Vaccines market size is projected to grow from US$ 9777.7 million in 2022 to US$ 12690 million in 2029; it is expected to grow at a CAGR of 12690 from 2023 to 2029.
Market competition is intense. Pfizer, GSK, Sanofi, Merck, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. Top 5 manufacturers accounted for 86.11% market share in 2019.
This report presents a comprehensive overview, market shares, and growth opportunities of Conjugate Vaccines market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Monovalent Conjugate Vaccines
Multivalent Conjugate Vaccines
Segmentation by application
Children
Adults
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Novartis
Neuron Biotech
Serum Institute of India
Pfizer
Sanofi Pasteur
Bharat Biotech
Biological
GlaxoSmithKline
Merck
CSL
Key Questions Addressed in this Report
What is the 10-year outlook for the global Conjugate Vaccines market?
What factors are driving Conjugate Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Conjugate Vaccines market opportunities vary by end market size?
How does Conjugate Vaccines break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Conjugate Vaccines Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Conjugate Vaccines by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Conjugate Vaccines by Country/Region, 2018, 2022 & 2029
2.2 Conjugate Vaccines Segment by Type
2.2.1 Monovalent Conjugate Vaccines
2.2.2 Multivalent Conjugate Vaccines
2.3 Conjugate Vaccines Sales by Type
2.3.1 Global Conjugate Vaccines Sales Market Share by Type (2018-2023)
2.3.2 Global Conjugate Vaccines Revenue and Market Share by Type (2018-2023)
2.3.3 Global Conjugate Vaccines Sale Price by Type (2018-2023)
2.4 Conjugate Vaccines Segment by Application
2.4.1 Children
2.4.2 Adults
2.5 Conjugate Vaccines Sales by Application
2.5.1 Global Conjugate Vaccines Sale Market Share by Application (2018-2023)
2.5.2 Global Conjugate Vaccines Revenue and Market Share by Application (2018-2023)
2.5.3 Global Conjugate Vaccines Sale Price by Application (2018-2023)
3 Global Conjugate Vaccines by Company
3.1 Global Conjugate Vaccines Breakdown Data by Company
3.1.1 Global Conjugate Vaccines Annual Sales by Company (2018-2023)
3.1.2 Global Conjugate Vaccines Sales Market Share by Company (2018-2023)
3.2 Global Conjugate Vaccines Annual Revenue by Company (2018-2023)
3.2.1 Global Conjugate Vaccines Revenue by Company (2018-2023)
3.2.2 Global Conjugate Vaccines Revenue Market Share by Company (2018-2023)
3.3 Global Conjugate Vaccines Sale Price by Company
3.4 Key Manufacturers Conjugate Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Conjugate Vaccines Product Location Distribution
3.4.2 Players Conjugate Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Conjugate Vaccines by Geographic Region
4.1 World Historic Conjugate Vaccines Market Size by Geographic Region (2018-2023)
4.1.1 Global Conjugate Vaccines Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Conjugate Vaccines Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Conjugate Vaccines Market Size by Country/Region (2018-2023)
4.2.1 Global Conjugate Vaccines Annual Sales by Country/Region (2018-2023)
4.2.2 Global Conjugate Vaccines Annual Revenue by Country/Region (2018-2023)
4.3 Americas Conjugate Vaccines Sales Growth
4.4 APAC Conjugate Vaccines Sales Growth
4.5 Europe Conjugate Vaccines Sales Growth
4.6 Middle East & Africa Conjugate Vaccines Sales Growth
5 Americas
5.1 Americas Conjugate Vaccines Sales by Country
5.1.1 Americas Conjugate Vaccines Sales by Country (2018-2023)
5.1.2 Americas Conjugate Vaccines Revenue by Country (2018-2023)
5.2 Americas Conjugate Vaccines Sales by Type
5.3 Americas Conjugate Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Conjugate Vaccines Sales by Region
6.1.1 APAC Conjugate Vaccines Sales by Region (2018-2023)
6.1.2 APAC Conjugate Vaccines Revenue by Region (2018-2023)
6.2 APAC Conjugate Vaccines Sales by Type
6.3 APAC Conjugate Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Conjugate Vaccines by Country
7.1.1 Europe Conjugate Vaccines Sales by Country (2018-2023)
7.1.2 Europe Conjugate Vaccines Revenue by Country (2018-2023)
7.2 Europe Conjugate Vaccines Sales by Type
7.3 Europe Conjugate Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Conjugate Vaccines by Country
8.1.1 Middle East & Africa Conjugate Vaccines Sales by Country (2018-2023)
8.1.2 Middle East & Africa Conjugate Vaccines Revenue by Country (2018-2023)
8.2 Middle East & Africa Conjugate Vaccines Sales by Type
8.3 Middle East & Africa Conjugate Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Conjugate Vaccines
10.3 Manufacturing Process Analysis of Conjugate Vaccines
10.4 Industry Chain Structure of Conjugate Vaccines
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Conjugate Vaccines Distributors
11.3 Conjugate Vaccines Customer
12 World Forecast Review for Conjugate Vaccines by Geographic Region
12.1 Global Conjugate Vaccines Market Size Forecast by Region
12.1.1 Global Conjugate Vaccines Forecast by Region (2024-2029)
12.1.2 Global Conjugate Vaccines Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Conjugate Vaccines Forecast by Type
12.7 Global Conjugate Vaccines Forecast by Application
13 Key Players Analysis
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Conjugate Vaccines Product Portfolios and Specifications
13.1.3 Novartis Conjugate Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Neuron Biotech
13.2.1 Neuron Biotech Company Information
13.2.2 Neuron Biotech Conjugate Vaccines Product Portfolios and Specifications
13.2.3 Neuron Biotech Conjugate Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Neuron Biotech Main Business Overview
13.2.5 Neuron Biotech Latest Developments
13.3 Serum Institute of India
13.3.1 Serum Institute of India Company Information
13.3.2 Serum Institute of India Conjugate Vaccines Product Portfolios and Specifications
13.3.3 Serum Institute of India Conjugate Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Serum Institute of India Main Business Overview
13.3.5 Serum Institute of India Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Conjugate Vaccines Product Portfolios and Specifications
13.4.3 Pfizer Conjugate Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Sanofi Pasteur
13.5.1 Sanofi Pasteur Company Information
13.5.2 Sanofi Pasteur Conjugate Vaccines Product Portfolios and Specifications
13.5.3 Sanofi Pasteur Conjugate Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Sanofi Pasteur Main Business Overview
13.5.5 Sanofi Pasteur Latest Developments
13.6 Bharat Biotech
13.6.1 Bharat Biotech Company Information
13.6.2 Bharat Biotech Conjugate Vaccines Product Portfolios and Specifications
13.6.3 Bharat Biotech Conjugate Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Bharat Biotech Main Business Overview
13.6.5 Bharat Biotech Latest Developments
13.7 Biological
13.7.1 Biological Company Information
13.7.2 Biological Conjugate Vaccines Product Portfolios and Specifications
13.7.3 Biological Conjugate Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Biological Main Business Overview
13.7.5 Biological Latest Developments
13.8 GlaxoSmithKline
13.8.1 GlaxoSmithKline Company Information
13.8.2 GlaxoSmithKline Conjugate Vaccines Product Portfolios and Specifications
13.8.3 GlaxoSmithKline Conjugate Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 GlaxoSmithKline Main Business Overview
13.8.5 GlaxoSmithKline Latest Developments
13.9 Merck
13.9.1 Merck Company Information
13.9.2 Merck Conjugate Vaccines Product Portfolios and Specifications
13.9.3 Merck Conjugate Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Merck Main Business Overview
13.9.5 Merck Latest Developments
13.10 CSL
13.10.1 CSL Company Information
13.10.2 CSL Conjugate Vaccines Product Portfolios and Specifications
13.10.3 CSL Conjugate Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 CSL Main Business Overview
13.10.5 CSL Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Conjugate Vaccines Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Conjugate Vaccines Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Monovalent Conjugate Vaccines
Table 4. Major Players of Multivalent Conjugate Vaccines
Table 5. Global Conjugate Vaccines Sales by Type (2018-2023) & (Units)
Table 6. Global Conjugate Vaccines Sales Market Share by Type (2018-2023)
Table 7. Global Conjugate Vaccines Revenue by Type (2018-2023) & ($ million)
Table 8. Global Conjugate Vaccines Revenue Market Share by Type (2018-2023)
Table 9. Global Conjugate Vaccines Sale Price by Type (2018-2023) & (USD/Unit)
Table 10. Global Conjugate Vaccines Sales by Application (2018-2023) & (Units)
Table 11. Global Conjugate Vaccines Sales Market Share by Application (2018-2023)
Table 12. Global Conjugate Vaccines Revenue by Application (2018-2023)
Table 13. Global Conjugate Vaccines Revenue Market Share by Application (2018-2023)
Table 14. Global Conjugate Vaccines Sale Price by Application (2018-2023) & (USD/Unit)
Table 15. Global Conjugate Vaccines Sales by Company (2018-2023) & (Units)
Table 16. Global Conjugate Vaccines Sales Market Share by Company (2018-2023)
Table 17. Global Conjugate Vaccines Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Conjugate Vaccines Revenue Market Share by Company (2018-2023)
Table 19. Global Conjugate Vaccines Sale Price by Company (2018-2023) & (USD/Unit)
Table 20. Key Manufacturers Conjugate Vaccines Producing Area Distribution and Sales Area
Table 21. Players Conjugate Vaccines Products Offered
Table 22. Conjugate Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Conjugate Vaccines Sales by Geographic Region (2018-2023) & (Units)
Table 26. Global Conjugate Vaccines Sales Market Share Geographic Region (2018-2023)
Table 27. Global Conjugate Vaccines Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Conjugate Vaccines Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Conjugate Vaccines Sales by Country/Region (2018-2023) & (Units)
Table 30. Global Conjugate Vaccines Sales Market Share by Country/Region (2018-2023)
Table 31. Global Conjugate Vaccines Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Conjugate Vaccines Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Conjugate Vaccines Sales by Country (2018-2023) & (Units)
Table 34. Americas Conjugate Vaccines Sales Market Share by Country (2018-2023)
Table 35. Americas Conjugate Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Conjugate Vaccines Revenue Market Share by Country (2018-2023)
Table 37. Americas Conjugate Vaccines Sales by Type (2018-2023) & (Units)
Table 38. Americas Conjugate Vaccines Sales by Application (2018-2023) & (Units)
Table 39. APAC Conjugate Vaccines Sales by Region (2018-2023) & (Units)
Table 40. APAC Conjugate Vaccines Sales Market Share by Region (2018-2023)
Table 41. APAC Conjugate Vaccines Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Conjugate Vaccines Revenue Market Share by Region (2018-2023)
Table 43. APAC Conjugate Vaccines Sales by Type (2018-2023) & (Units)
Table 44. APAC Conjugate Vaccines Sales by Application (2018-2023) & (Units)
Table 45. Europe Conjugate Vaccines Sales by Country (2018-2023) & (Units)
Table 46. Europe Conjugate Vaccines Sales Market Share by Country (2018-2023)
Table 47. Europe Conjugate Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Conjugate Vaccines Revenue Market Share by Country (2018-2023)
Table 49. Europe Conjugate Vaccines Sales by Type (2018-2023) & (Units)
Table 50. Europe Conjugate Vaccines Sales by Application (2018-2023) & (Units)
Table 51. Middle East & Africa Conjugate Vaccines Sales by Country (2018-2023) & (Units)
Table 52. Middle East & Africa Conjugate Vaccines Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Conjugate Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Conjugate Vaccines Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Conjugate Vaccines Sales by Type (2018-2023) & (Units)
Table 56. Middle East & Africa Conjugate Vaccines Sales by Application (2018-2023) & (Units)
Table 57. Key Market Drivers & Growth Opportunities of Conjugate Vaccines
Table 58. Key Market Challenges & Risks of Conjugate Vaccines
Table 59. Key Industry Trends of Conjugate Vaccines
Table 60. Conjugate Vaccines Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Conjugate Vaccines Distributors List
Table 63. Conjugate Vaccines Customer List
Table 64. Global Conjugate Vaccines Sales Forecast by Region (2024-2029) & (Units)
Table 65. Global Conjugate Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Conjugate Vaccines Sales Forecast by Country (2024-2029) & (Units)
Table 67. Americas Conjugate Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Conjugate Vaccines Sales Forecast by Region (2024-2029) & (Units)
Table 69. APAC Conjugate Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Conjugate Vaccines Sales Forecast by Country (2024-2029) & (Units)
Table 71. Europe Conjugate Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Conjugate Vaccines Sales Forecast by Country (2024-2029) & (Units)
Table 73. Middle East & Africa Conjugate Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Conjugate Vaccines Sales Forecast by Type (2024-2029) & (Units)
Table 75. Global Conjugate Vaccines Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Conjugate Vaccines Sales Forecast by Application (2024-2029) & (Units)
Table 77. Global Conjugate Vaccines Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Novartis Basic Information, Conjugate Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 79. Novartis Conjugate Vaccines Product Portfolios and Specifications
Table 80. Novartis Conjugate Vaccines Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 81. Novartis Main Business
Table 82. Novartis Latest Developments
Table 83. Neuron Biotech Basic Information, Conjugate Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 84. Neuron Biotech Conjugate Vaccines Product Portfolios and Specifications
Table 85. Neuron Biotech Conjugate Vaccines Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 86. Neuron Biotech Main Business
Table 87. Neuron Biotech Latest Developments
Table 88. Serum Institute of India Basic Information, Conjugate Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. Serum Institute of India Conjugate Vaccines Product Portfolios and Specifications
Table 90. Serum Institute of India Conjugate Vaccines Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 91. Serum Institute of India Main Business
Table 92. Serum Institute of India Latest Developments
Table 93. Pfizer Basic Information, Conjugate Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. Pfizer Conjugate Vaccines Product Portfolios and Specifications
Table 95. Pfizer Conjugate Vaccines Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 96. Pfizer Main Business
Table 97. Pfizer Latest Developments
Table 98. Sanofi Pasteur Basic Information, Conjugate Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. Sanofi Pasteur Conjugate Vaccines Product Portfolios and Specifications
Table 100. Sanofi Pasteur Conjugate Vaccines Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 101. Sanofi Pasteur Main Business
Table 102. Sanofi Pasteur Latest Developments
Table 103. Bharat Biotech Basic Information, Conjugate Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. Bharat Biotech Conjugate Vaccines Product Portfolios and Specifications
Table 105. Bharat Biotech Conjugate Vaccines Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 106. Bharat Biotech Main Business
Table 107. Bharat Biotech Latest Developments
Table 108. Biological Basic Information, Conjugate Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 109. Biological Conjugate Vaccines Product Portfolios and Specifications
Table 110. Biological Conjugate Vaccines Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 111. Biological Main Business
Table 112. Biological Latest Developments
Table 113. GlaxoSmithKline Basic Information, Conjugate Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. GlaxoSmithKline Conjugate Vaccines Product Portfolios and Specifications
Table 115. GlaxoSmithKline Conjugate Vaccines Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 116. GlaxoSmithKline Main Business
Table 117. GlaxoSmithKline Latest Developments
Table 118. Merck Basic Information, Conjugate Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 119. Merck Conjugate Vaccines Product Portfolios and Specifications
Table 120. Merck Conjugate Vaccines Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 121. Merck Main Business
Table 122. Merck Latest Developments
Table 123. CSL Basic Information, Conjugate Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 124. CSL Conjugate Vaccines Product Portfolios and Specifications
Table 125. CSL Conjugate Vaccines Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 126. CSL Main Business
Table 127. CSL Latest Developments
List of Figures
Figure 1. Picture of Conjugate Vaccines
Figure 2. Conjugate Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Conjugate Vaccines Sales Growth Rate 2018-2029 (Units)
Figure 7. Global Conjugate Vaccines Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Conjugate Vaccines Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Monovalent Conjugate Vaccines
Figure 10. Product Picture of Multivalent Conjugate Vaccines
Figure 11. Global Conjugate Vaccines Sales Market Share by Type in 2022
Figure 12. Global Conjugate Vaccines Revenue Market Share by Type (2018-2023)
Figure 13. Conjugate Vaccines Consumed in Children
Figure 14. Global Conjugate Vaccines Market: Children (2018-2023) & (Units)
Figure 15. Conjugate Vaccines Consumed in Adults
Figure 16. Global Conjugate Vaccines Market: Adults (2018-2023) & (Units)
Figure 17. Global Conjugate Vaccines Sales Market Share by Application (2022)
Figure 18. Global Conjugate Vaccines Revenue Market Share by Application in 2022
Figure 19. Conjugate Vaccines Sales Market by Company in 2022 (Units)
Figure 20. Global Conjugate Vaccines Sales Market Share by Company in 2022
Figure 21. Conjugate Vaccines Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Conjugate Vaccines Revenue Market Share by Company in 2022
Figure 23. Global Conjugate Vaccines Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Conjugate Vaccines Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Conjugate Vaccines Sales 2018-2023 (Units)
Figure 26. Americas Conjugate Vaccines Revenue 2018-2023 ($ Millions)
Figure 27. APAC Conjugate Vaccines Sales 2018-2023 (Units)
Figure 28. APAC Conjugate Vaccines Revenue 2018-2023 ($ Millions)
Figure 29. Europe Conjugate Vaccines Sales 2018-2023 (Units)
Figure 30. Europe Conjugate Vaccines Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Conjugate Vaccines Sales 2018-2023 (Units)
Figure 32. Middle East & Africa Conjugate Vaccines Revenue 2018-2023 ($ Millions)
Figure 33. Americas Conjugate Vaccines Sales Market Share by Country in 2022
Figure 34. Americas Conjugate Vaccines Revenue Market Share by Country in 2022
Figure 35. Americas Conjugate Vaccines Sales Market Share by Type (2018-2023)
Figure 36. Americas Conjugate Vaccines Sales Market Share by Application (2018-2023)
Figure 37. United States Conjugate Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Conjugate Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Conjugate Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Conjugate Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Conjugate Vaccines Sales Market Share by Region in 2022
Figure 42. APAC Conjugate Vaccines Revenue Market Share by Regions in 2022
Figure 43. APAC Conjugate Vaccines Sales Market Share by Type (2018-2023)
Figure 44. APAC Conjugate Vaccines Sales Market Share by Application (2018-2023)
Figure 45. China Conjugate Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Conjugate Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Conjugate Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Conjugate Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Conjugate Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Conjugate Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Conjugate Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Conjugate Vaccines Sales Market Share by Country in 2022
Figure 53. Europe Conjugate Vaccines Revenue Market Share by Country in 2022
Figure 54. Europe Conjugate Vaccines Sales Market Share by Type (2018-2023)
Figure 55. Europe Conjugate Vaccines Sales Market Share by Application (2018-2023)
Figure 56. Germany Conjugate Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Conjugate Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Conjugate Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Conjugate Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Conjugate Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Conjugate Vaccines Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Conjugate Vaccines Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Conjugate Vaccines Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Conjugate Vaccines Sales Market Share by Application (2018-2023)
Figure 65. Egypt Conjugate Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Conjugate Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Conjugate Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Conjugate Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Conjugate Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Conjugate Vaccines in 2022
Figure 71. Manufacturing Process Analysis of Conjugate Vaccines
Figure 72. Industry Chain Structure of Conjugate Vaccines
Figure 73. Channels of Distribution
Figure 74. Global Conjugate Vaccines Sales Market Forecast by Region (2024-2029)
Figure 75. Global Conjugate Vaccines Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Conjugate Vaccines Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Conjugate Vaccines Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Conjugate Vaccines Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Conjugate Vaccines Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の結合型ワクチン市場予測 2023年-2029年] (コード：LP23MY4386)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の結合型ワクチン市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 13価肺炎球菌結合型ワクチンのグローバル市場展望 2023年-2029年：バイアル、充填済み
  • 世界のワクチンデリバリーデバイス市場予測 2023年-2029年
  • 世界のコロナウイルス迅速検査キット市場予測 2023年-2029年
  • 世界の新型コロナウイルス感染症用迅速検査キット市場予測 2023年-2029年
  • 世界のヒトオステオカルシンELISAキット市場予測 2023年-2029年
  • 世界の腫瘍検出キット市場予測 2023年-2029年
  • 世界の総胆汁酸アッセイキット市場予測 2023年-2029年
  • 世界の乱用薬物検査装置市場予測 2023年-2029年
  • 世界のトランスフェリン市場予測 2023年-2029年
  • 世界の臍ヘルニア治療用プロテーゼ市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆